HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Walther Kuhn Selected Research
Walther Kuhn Research Topics
Disease
33
Neoplasms (Cancer)
03/2020 - 07/2003
28
Breast Neoplasms (Breast Cancer)
06/2019 - 12/2008
25
Ovarian Neoplasms (Ovarian Cancer)
03/2020 - 08/2003
8
Ovarian Epithelial Carcinoma
01/2016 - 03/2006
5
Neoplasm Metastasis (Metastasis)
01/2019 - 08/2003
3
Infections
06/2018 - 09/2002
3
Carcinoma (Carcinomatosis)
09/2008 - 08/2003
2
Endometrial Neoplasms (Endometrial Cancer)
10/2012 - 04/2004
2
Carcinogenesis
01/2009 - 12/2006
1
Peritoneal Neoplasms
03/2020
1
Vascular System Injuries
08/2019
1
Cysts
08/2019
1
Pulmonary Embolism
08/2019
1
Disease Progression
01/2019
1
Choriocarcinoma
01/2019
1
Hepatitis E
06/2018
1
Vulvar Neoplasms (Vulvar Cancer)
11/2017
1
Breast Diseases (Breast Disease)
06/2017
1
Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017
1
Lymphatic Metastasis
04/2016
1
Gynecomastia
07/2015
1
Aneuploidy (Aneuploid)
04/2015
1
Male Breast Neoplasms (Male Breast Cancer)
12/2013
1
Thrombosis (Thrombus)
07/2013
1
Drug-Related Side Effects and Adverse Reactions
11/2012
1
Endometrioid Carcinoma
10/2012
1
Melanoma (Melanoma, Malignant)
10/2011
Drug/Important Bio-Agent (IBA)
8
Paclitaxel (Taxol)
FDA Link
Generic
07/2013 - 09/2003
7
Biomarkers (Surrogate Marker)
IBA
04/2018 - 09/2010
6
Proteins (Proteins, Gene)
FDA Link
06/2018 - 08/2003
6
Carboplatin (JM8)
FDA Link
Generic
05/2010 - 09/2003
4
Antigens
IBA
06/2018 - 09/2008
4
Tumor Biomarkers (Tumor Markers)
IBA
04/2018 - 11/2011
4
taxane
IBA
06/2015 - 09/2009
4
Anthracyclines
IBA
04/2015 - 09/2009
4
Epirubicin (Ellence)
FDA Link
Generic
07/2013 - 03/2006
4
Paraffin
IBA
10/2012 - 07/2003
3
Hormones (Hormone)
IBA
06/2018 - 04/2015
3
Platinum
IBA
06/2015 - 10/2006
2
MicroRNAs (MicroRNA)
IBA
06/2019 - 04/2018
2
Messenger RNA (mRNA)
IBA
06/2018 - 05/2007
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
10/2017 - 06/2017
2
Carcinoembryonic Antigen
IBA
10/2017 - 06/2017
2
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
06/2017 - 07/2010
2
Matrix Metalloproteinases (MMPs)
IBA
02/2017 - 08/2003
2
Type II DNA Topoisomerases (Topoisomerase II)
IBA
04/2015 - 12/2013
2
Calponins
IBA
11/2014 - 11/2011
2
Calmodulin (Calcium-Dependent Activator Protein)
IBA
12/2013 - 11/2011
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2013 - 06/2010
2
Interleukin-6 (Interleukin 6)
IBA
10/2011 - 07/2010
2
DNA (Deoxyribonucleic Acid)
IBA
05/2011 - 04/2004
2
Formaldehyde (Formol)
FDA Link
12/2009 - 12/2008
2
Docetaxel (Taxotere)
FDA Link
09/2009 - 09/2009
2
Topotecan (Hycamtin)
FDA Link
Generic
08/2009 - 08/2006
1
N 30
IBA
01/2020
1
Methotrexate (Mexate)
FDA Link
Generic
01/2019
1
Etoposide (VP 16)
FDA Link
Generic
01/2019
1
Ribavirin (Virazole)
FDA Link
Generic
06/2018
1
Transaminases (Aminotransferases)
IBA
06/2018
1
Hydrolases
IBA
06/2018
1
Folic Acid (Vitamin M)
FDA Link
Generic
06/2018
1
Radioisotopes (Radionuclides)
IBA
06/2018
1
RNA (Ribonucleic Acid)
IBA
04/2018
1
Complement System Proteins (Complement)
IBA
11/2017
1
Immune Checkpoint Inhibitors
IBA
11/2017
1
Carbohydrates
IBA
10/2017
1
Oxygen (Dioxygen)
IBA
10/2017
1
Stem Cell Factor
IBA
06/2017
1
Osteopontin
IBA
06/2017
1
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
06/2017
1
Tissue Inhibitor of Metalloproteinase-1
IBA
04/2015
1
Tissue Inhibitor of Metalloproteinases
IBA
04/2015
1
Antibodies
IBA
12/2013
1
Ubiquitin
IBA
12/2013
1
trioctyl phosphine oxide (TOPO)
IBA
12/2013
1
Phenobarbital (Luminal)
FDA Link
12/2013
1
Indicators and Reagents (Reagents)
IBA
09/2013
1
Epoetin Alfa (Epogen)
FDA Link
07/2013
1
Cadherins (E-Cadherin)
IBA
05/2013
1
Emetics
IBA
11/2012
1
Monoclonal Antibodies
IBA
10/2012
1
Vaccines
IBA
10/2011
1
Poly I-C
IBA
10/2011
Therapy/Procedure
10
Therapeutics
06/2018 - 06/2009
10
Drug Therapy (Chemotherapy)
04/2016 - 09/2003
9
Neoadjuvant Therapy
04/2016 - 10/2005
4
Adjuvant Chemotherapy
04/2015 - 09/2009
3
Operative Surgical Procedures
03/2020 - 01/2014
3
Cytoreduction Surgical Procedures
03/2020 - 09/2009
2
Hyperthermic Intraperitoneal Chemotherapy
03/2020 - 01/2016
2
Hysterectomy
08/2019 - 01/2019
2
Lymph Node Excision (Lymph Node Dissection)
08/2019 - 10/2012
2
Immunotherapy
10/2011 - 07/2010
1
Laparotomy
08/2019
1
Salpingo-oophorectomy
08/2019
1
Mastectomy (Mammectomy)
01/2017
1
Lipectomy (Liposuction)
07/2015
1
Subcutaneous Mastectomy
07/2015
1
Aftercare (After-Treatment)
06/2015
1
Colectomy
01/2014